[go: up one dir, main page]

DE69424183D1 - 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten - Google Patents

6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten

Info

Publication number
DE69424183D1
DE69424183D1 DE69424183T DE69424183T DE69424183D1 DE 69424183 D1 DE69424183 D1 DE 69424183D1 DE 69424183 T DE69424183 T DE 69424183T DE 69424183 T DE69424183 T DE 69424183T DE 69424183 D1 DE69424183 D1 DE 69424183D1
Authority
DE
Germany
Prior art keywords
unsubstituted
compounds
imidazolinylamino
alpha
alkanyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69424183T
Other languages
English (en)
Other versions
DE69424183T2 (de
Inventor
Lee Cupps
Julian Maurer
Jeff Ares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Lincoln
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/326,564 external-priority patent/US5578607A/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69424183D1 publication Critical patent/DE69424183D1/de
Application granted granted Critical
Publication of DE69424183T2 publication Critical patent/DE69424183T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69424183T 1993-12-17 1994-12-15 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten Expired - Lifetime DE69424183T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16934393A 1993-12-17 1993-12-17
US08/326,564 US5578607A (en) 1993-12-17 1994-10-20 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
PCT/US1994/014293 WO1995016683A1 (en) 1993-12-17 1994-12-15 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists

Publications (2)

Publication Number Publication Date
DE69424183D1 true DE69424183D1 (de) 2000-05-31
DE69424183T2 DE69424183T2 (de) 2001-02-15

Family

ID=26864975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424183T Expired - Lifetime DE69424183T2 (de) 1993-12-17 1994-12-15 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten

Country Status (23)

Country Link
US (1) US5739148A (de)
EP (1) EP0736020B1 (de)
JP (1) JPH09511483A (de)
CN (1) CN1046718C (de)
AT (1) ATE192150T1 (de)
AU (1) AU699041B2 (de)
BR (1) BR9408335A (de)
CA (1) CA2179264C (de)
CZ (1) CZ285481B6 (de)
DE (1) DE69424183T2 (de)
DK (1) DK0736020T3 (de)
ES (1) ES2146307T3 (de)
FI (1) FI962491L (de)
GR (1) GR3033515T3 (de)
HK (1) HK1013072A1 (de)
HU (1) HU217841B (de)
NO (1) NO308662B1 (de)
NZ (1) NZ333370A (de)
PL (1) PL180392B1 (de)
PT (1) PT736020E (de)
SG (1) SG55141A1 (de)
SK (1) SK77096A3 (de)
WO (1) WO1995016683A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW527355B (en) 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
CA2559282A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
JP2007538004A (ja) * 2004-03-18 2007-12-27 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法
CA2559285A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
PL1742642T3 (pl) * 2004-04-14 2009-06-30 Gilead Sciences Inc Analogi fosfonianowe związków inhibitorów integrazy HIV
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
WO2010057006A1 (en) * 2008-11-13 2010-05-20 Link Medicine Corporation Azaquinolinone derivatives and uses thereof
RU2014106364A (ru) * 2011-07-25 2015-08-27 Аллерган, Инк. Производные n-(имидазолидин-2-илидин)хинолина как модуляторы адренергических рецепторов альфа-2

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
US4036976A (en) * 1973-04-05 1977-07-19 Sandoz, Inc. Substituted imidazolinylamino-indazoles
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
DE3071229D1 (en) * 1979-08-23 1985-12-19 Beecham Group Plc Anti-diarrhoea veterinary composition
US4436913A (en) * 1980-09-05 1984-03-13 Siegfried Aktiengesellschaft 1H- and 2H- indazole derivatives
FR2638356A1 (fr) * 1988-10-28 1990-05-04 Anben Nouveaux derives de la 2-arylimino-imidazolidine pour diminuer la pression intra-oculaire et traiter le glaucome
US5021410A (en) * 1989-05-22 1991-06-04 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5231096A (en) * 1989-10-12 1993-07-27 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents

Also Published As

Publication number Publication date
HUT76277A (en) 1997-07-28
CA2179264A1 (en) 1995-06-22
AU1306395A (en) 1995-07-03
CN1046718C (zh) 1999-11-24
ATE192150T1 (de) 2000-05-15
EP0736020B1 (de) 2000-04-26
CZ175396A3 (en) 1996-11-13
CN1137793A (zh) 1996-12-11
CA2179264C (en) 1999-05-18
NO962536D0 (no) 1996-06-14
WO1995016683A1 (en) 1995-06-22
US5739148A (en) 1998-04-14
AU699041B2 (en) 1998-11-19
HU9601659D0 (en) 1996-08-28
ES2146307T3 (es) 2000-08-01
EP0736020A1 (de) 1996-10-09
PL180392B1 (pl) 2001-01-31
CZ285481B6 (cs) 1999-08-11
FI962491L (fi) 1996-07-26
NZ333370A (en) 2001-03-30
PT736020E (pt) 2000-10-31
DK0736020T3 (da) 2000-08-07
NO962536L (no) 1996-08-02
NO308662B1 (no) 2000-10-09
GR3033515T3 (en) 2000-09-29
PL315060A1 (en) 1996-09-30
FI962491A0 (fi) 1996-06-14
BR9408335A (pt) 1997-08-19
HK1013072A1 (en) 1999-08-13
SK77096A3 (en) 1997-02-05
JPH09511483A (ja) 1997-11-18
SG55141A1 (en) 1998-12-21
DE69424183T2 (de) 2001-02-15
HU217841B (hu) 2000-04-28

Similar Documents

Publication Publication Date Title
NO962539L (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
DE69424183D1 (de) 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten
FI980341A0 (fi) 2-oksi-indolijohdannaisia
DE69505542D1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
NO962538D0 (no) 6-(2-imidazolinylamino)kinoksalin-forbindelser anvendbare som -2-adrenoceptor-agonister
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
FI962492A0 (fi) Alpha-2-adrenoseptoriagonisteina käyttökelpoisia 7-(2-imidatsolinyyliamino)kinoliiniyhdisteitä
FI920435A0 (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
DE69827614D1 (de) Chinoxalindionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA